Skip to main content
logo
EyePoint Pharmaceuticals, Inc. (EYPT)
NASDAQ: EYPT · Real-Time Price · USD
11.63
+0.08 (0.69%)
At close: Oct 17, 2025, 4:00 PM EDT
11.58
-0.05 (-0.43%)
After-hours: Oct 17, 2025, 7:55 PM EDT

EyePoint Pharmaceuticals Revenue

EyePoint Pharmaceuticals had revenue of $5.33M in the quarter ending June 30, 2025, a decrease of -43.73%. This brings the company's revenue in the last twelve months to $51.90M, up 2.99% year-over-year. In the year 2024, EyePoint Pharmaceuticals had annual revenue of $43.27M, down -5.97%.

Revenue (ttm)
$51.90M
Revenue Growth
+2.99%
P/S Ratio
14.50
Revenue / Employee
$314,533
Employees
165
Market Cap
801.63M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202443.27M-2.75M-5.97%
Dec 31, 202346.02M4.61M11.14%
Dec 31, 202241.40M4.47M12.09%
Dec 31, 202136.94M2.50M7.27%
Dec 31, 202034.44M14.07M69.10%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group422.82B
Johnson & Johnson92.15B
Merck & Co.63.62B
AbbVie58.33B
AstraZeneca56.50B
Novartis AG55.19B
Eli Lilly and Company53.26B
Novo Nordisk49.11B
Revenue Rankings

EYPT News

More News